Multicentre pilot-study for the therapy of medulloblastoma of adults (NOA-07) - NOA-07

Freistaat Bayern, represented by the University of Regensburg0 个研究点目标入组 30 人开始时间: 2009年8月6日最近更新: 2019年4月30日

试验速览

暂无简介。

•Inclusion is possible on attaining the age of 18.
•The intracranial tumor has to be a medulloblastoma.
•The tumor has to be first diagnosed at that time.
•The patient must not have received chemotherapy or radiotherapy yet.
•The Karnofsky-Score has to be at least 70%.
•The patient has to give a written consent.
•Pregnancy test has to be negative before baseline visit and has to be repeated every 4 weeks.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 30
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 30

•Inclusion is not possible for patients not having reached the age of 18.
•Inclusion is not possible in case of doubtful diagnosis.
•Relapse of a medulloblastoma that has already been treated with radiotherapy or chemotherapy.
•Investigator have to follow the summary of product characteristics (SmPC) for contraindications and safty warnings of the used substances.

发起方

Freistaat Bayern, represented by the University of Regensburg